SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Akari Therapeutics to Highlight RNA-Splicing ADC Payload Strategy

Akari Therapeutics plans to discuss the potential of RNA-splicing payloads to drive broad anti-tumor effects at the 3rd Annual ADC Payload Summit.

AKTX

Related stories